Literature DB >> 7227398

Value of various treatments for retroperitoneal fibrosis.

L V Wagenknecht, J C Hardy.   

Abstract

Based on retrospective analysis of 430 cases of retroperitoneal fibrosis, a classification into various etiological groups and an evaluation of the best diagnostic approach and treatment was possible. In patients presenting moderate upper urinary dilation corticosteroids alone proved to be of value in 93% of cases. Azathioprin given in combination with corticosteroids seems to be effective. The surgical 'therapy of choice' was ureterolysis with an effective intraperitoneal transposition. Ureteral restenosis after this procedure (in 22%) occurred mainly when it was not combined with long-term corticosteroid therapy. When the lower half of the ureter is involved we favor ureterolysis, its prevesical section, complete intraperitoneal transposition and a primary psoas-hitch bladder flap.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7227398     DOI: 10.1159/000473218

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

Review 1.  [Chronic periaortitis].

Authors:  J H Schirmer; M Both; F Moosig
Journal:  Internist (Berl)       Date:  2013-12       Impact factor: 0.743

Review 2.  Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature.

Authors:  K Warnatz; A G Keskin; M Uhl; C Scholz; A Katzenwadel; P Vaith; H H Peter; U A Walker
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

3.  Renal autotransplantation for idiopathic retroperitoneal fibrosis.

Authors:  H Oesterwitz; S Lenk; E Hengst; P Althaus
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

4.  [Retroperitoneal fibrosis].

Authors:  S Burkhardt Soares; S Kukuk; A S Brandt; A Fehr; S Roth
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

5.  Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis.

Authors:  A S Scavalli; A Spadaro; V Riccieri; G P Ricciuti; E Taccari; M Marini; A Zoppini
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

6.  Retroperitoneal fibrosis after long-term daily use of ergotamine.

Authors:  L Damstrup; T T Jensen
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

7.  Prognostic factors in retroperitoneal fibrosis.

Authors:  I Sinescu; C Surcel; C Mirvald; C Chibelean; C Gîngu; D Avram; M Hîrza; M Manu; R Lazar; C Savu; A Udrea
Journal:  J Med Life       Date:  2010 Jan-Mar

8.  An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI.

Authors:  Alexander Sascha Brandt; Lars Kamper; Sonja Kukuk; Werner Piroth; Patrick Haage; Stephan Roth
Journal:  J Clin Med Res       Date:  2013-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.